Global pharmaceutical leaders said on Thursday that cell therapy, artificial intelligence (AI)-driven drug development and diagnostics, digital healthcare, and aesthetic medicine are four frontiers that will lead South Korea’s biotech industry, as per a report by Pulse, the English service of Maeil Business Newspaper Korea.
​Global pharmaceutical leaders said on Thursday that cell therapy, artificial intelligence (AI)-driven drug development and diagnostics, digital healthcare, and aesthetic medicine are four frontiers that will lead South Korea’s biotech industry, as per a report by Pulse, the English service of Maeil Business Newspaper Korea. by Soban News (international And National News)
